company background image
MDTC34 logo

Medtronic BOVESPA:MDTC34 Stock Report

Last Price

R$270.25

Market Cap

R$683.2b

7D

1.9%

1Y

26.9%

Updated

27 Jan, 2025

Data

Company Financials +

MDTC34 Stock Overview

Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. More details

MDTC34 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health3/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

Medtronic plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medtronic
Historical stock prices
Current Share PriceUS$270.25
52 Week HighUS$270.77
52 Week LowUS$201.60
Beta0.84
1 Month Change10.04%
3 Month Change2.99%
1 Year Change26.91%
3 Year Change-1.61%
5 Year Change8.17%
Change since IPO92.64%

Recent News & Updates

Recent updates

Shareholder Returns

MDTC34BR Medical EquipmentBR Market
7D1.9%3.4%1.7%
1Y26.9%13.6%-8.1%

Return vs Industry: MDTC34 exceeded the BR Medical Equipment industry which returned 13.3% over the past year.

Return vs Market: MDTC34 exceeded the BR Market which returned -10.3% over the past year.

Price Volatility

Is MDTC34's price volatile compared to industry and market?
MDTC34 volatility
MDTC34 Average Weekly Movement4.3%
Medical Equipment Industry Average Movement6.3%
Market Average Movement5.4%
10% most volatile stocks in BR Market9.9%
10% least volatile stocks in BR Market3.2%

Stable Share Price: MDTC34 has not had significant price volatility in the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine MDTC34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
194995,000Geoff Marthawww.medtronic.com

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products.

Medtronic plc Fundamentals Summary

How do Medtronic's earnings and revenue compare to its market cap?
MDTC34 fundamental statistics
Market capR$683.15b
Earnings (TTM)R$25.33b
Revenue (TTM)R$194.91b

27.6x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDTC34 income statement (TTM)
RevenueUS$33.00b
Cost of RevenueUS$11.42b
Gross ProfitUS$21.58b
Other ExpensesUS$17.29b
EarningsUS$4.29b

Last Reported Earnings

Oct 25, 2024

Next Earnings Date

Feb 18, 2025

Earnings per share (EPS)3.34
Gross Margin65.40%
Net Profit Margin13.00%
Debt/Equity Ratio58.0%

How did MDTC34 perform over the long term?

See historical performance and comparison

Dividends

3.0%

Current Dividend Yield

85%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/27 23:57
End of Day Share Price 2025/01/27 00:00
Earnings2024/10/25
Annual Earnings2024/04/26

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medtronic plc is covered by 64 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kadambari DaptardarAccountability Research Corporation
Harshit GuptaAccountability Research Corporation
David ToungArgus Research Company